Litcius/Paper detail

Application of cell membrane-functionalized biomimetic nanoparticles in the treatment of glioma

Guangchuan Zhang, Minghao Yao, Shanshan Ma, Kun Zhang, Yujue Wang, Zhimin Wang, Jiaheng Liang, Shan Dai, Rui‐Mei Jin, Fangxia Guan

2023Journal of Materials Chemistry B15 citationsDOI

Abstract

Glioma is one of the most common malignant tumors with characteristics of strong invasion and high postoperative recurrence rate, which seriously threatens human health. Nanoparticles as an emerging drug delivery system have promoted the development of glioma therapy. However, blocking of nanoparticles by the blood-brain barrier is still serious problem for the use of nanoparticles in glioma therapy. In this context, traditional nanoparticles are dressed with natural cell membranes to prepare biomimetic nanoparticles. Biomimetic nanoparticles show longer blood circulation time, excellent homologous targeting and outstanding immune escape capacity, which significantly improve the accumulation of nanoparticles at the tumor site. The therapeutic effect for glioma has been raised to an advanced level. This review focuses on the preparations and applications of cell membrane-functionalized biomimetic nanoparticles, as while as the advantages and problems of biomimetic nanoparticles in the treatment of glioma. In particular, the approach of using biomimetic nanoparticles to cross the blood-brain barrier is analyzed, in the hope of providing new ideas for further developments in crossing the blood-brain barrier and in glioma therapy.

Topics & Concepts

GliomaMembraneNanoparticleMaterials scienceNanotechnologyCellCell membraneChemistryCancer researchMedicineBiochemistryNanoparticle-Based Drug DeliveryRNA Interference and Gene DeliveryNanoplatforms for cancer theranostics
Application of cell membrane-functionalized biomimetic nanoparticles in the treatment of glioma | Litcius